
Please contact the doctor's office to verify that your insurance is accepted.
Dr. Mizrachi received his medical degree from the Hebrew University and Hadassah Medical School in Jerusalem and then completed a residency in Otolaryngology-Head and Neck Surgery at Rabin Medical Center, a leading tertiary care center in Israel, which is also the largest cancer center in the country serving a population of approximately 4.5 million people. Following that, Dr. Mizrachi pursued advanced training in head and neck oncologic surgery and translational research at Memorial Sloan-Kettering Cancer Center in New York.
After completing his fellowship, Dr. Mizrachi returned to Rabin Medical Center and practiced there as a full-time surgeon-scientist for 8 years before moving b...
The Global Immune-Nutrition-Inflammation Index (GINI) as a Candidate Prognostic Marker in Patients with Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab.
Revisiting the prognostic role of extranodal extension in oral cavity squamous cell carcinoma: minor versus major extension matters.
Airway Risk in Angioedema: Validation of a Clinical Triage Algorithm for ENT Referral.